Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: yosi s who wrote (604)	3/4/1999 8:41:00 PM
From: Tony van Werkhooven	Read Replies (1) \| Respond to of 1386

Yosi- do you know if there will be a scheduled conference call? Thanks Tony

To: yosi s who wrote (604)	3/5/1999 8:53:00 AM
From: Dr. John M. de Castro	Read Replies (2) \| Respond to of 1386

An analysis of PARS cash flows during Q4 suggests that PARS drew down about $300K from the line of credit in December. This suggests that they intend to draw down the first $3 million at a rapid pace; before the 6 month window is complete. The registration of the million shares also announced would appear to back this up. This taken together with the fact that the investor has stated an intention to sell these shares on the open market suggests that the selling pressure on PARS common stock should continue at least for the next few months. John de C